Addressing the complexities of endometriosis is critical, considering its global impact on millions of women. Unfortunately, the condition remains underexplored, leading to delayed diagnoses and lack of effective treatment. Excitingly, there's promising progress on the horizon, thanks to Prof. Hugo Vankelecom's research group at KU Leuven in Belgium. They're utilizing advanced cellular organoids to deepen our understanding of the disease and accelerate novel drug discovery. Now, with the support of the Danish BioInnovation Institute's incubation program, the team is poised to chart a course toward industrial success. Addressing the complexities of endometriosis is critical, considering its global impact on millions of women. Unfortunately, the condition remains underexplored, leading to delayed diagnoses and lack of effective treatment. 

From LinkedIn - BioVox